Affiliation:
1. Department of Pediatrics, Pediatric Neurology Division, All India Institute of Medical Sciences, Rishikesh, Uttarakhand, India
2. Department of Neurology, IQRAA International Hospital and Research Centre, Kozhikode, Kerala, India
Abstract
Abstract
Introduction:
There is no bedside clinical examination-based prediction score for Duchenne muscular dystrophy/Becker muscular dystrophy (DMD/BMD) in children with neuromuscular diseases (NMDs) presenting with proximal limb-girdle weakness.
Methods:
We compared the details of 200 cases of lower motor neuron type of weakness and had some proximal limb-girdle muscle weakness and divided them into 2 groups: with/without a confirmed diagnosis of DMD/BMD. We determined the predictive factors associated with a diagnosis of DMD/BMD using multivariate binary logistic regression. We assessed our proposed prognostic model using both discrimination and calibration and subsequently used the bootstrap method to successfully validate the model internally.
Results:
A total of 121 patients had DMD/BMD and the rest of the patients had other diagnoses. Male gender, presence of Gower’s sign, valley sign, toe walking, calf pseudohypertrophy, and tongue hypertrophy were independent predictors for a confirmed diagnosis of DMD/BMD and included in the final CVT2MG score (Calf pseudohypertrophy, Valley sign, Toe walking, Tongue hypertrophy, Male gender, and Gower’s sign). The final model showed good discrimination (AUC = 87.4% [95% CI: 80.5–92.3%, P < 0.001]) and calibration (P = 0.57). A score of 6 or above appeared to be the best cutoff for discriminating between the DMD/BMD group and the rest of the group with both sensitivity and specificity of 98%. The interrater reliability was almost perfect between two pediatric neurologists and strong between a pediatric neurologist and a pediatric neurology trainee resident (k = 0.91 and 0.87).
Conclusion:
The CVT2MG score has good sensitivity and specificity in predicting a confirmed diagnosis of DMD/BMD in subsequent tests.
Reference31 articles.
1. The dystrophinopathies;Thangarajh;Contin Minneap Minn,2019
2. Diagnosis and management of Duchenne muscular dystrophy, part 1:Diagnosis, and neuromuscular, rehabilitation, endocrine, and gastrointestinal and nutritional management;Birnkrant;Lancet Neurol,2018
3. Gene therapy for Duchenne muscular dystrophy:Expectations and challenges;Rodino-Klapac;Arch Neurol,2007
4. Duchenne muscular dystrophy;Duan;Nat Rev Dis Primer,2021
5. The clinical course of Duchenne muscular dystrophy in the corticosteroid treatment era:A systematic literature review;Szabo;Orphanet J Rare Dis,2021
Cited by
2 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献